Back
Janux Therapeutics Stock Price Chart
![](/images/offers/ims/large/offer8.jpg)
Forget AI THIS is Way Bigger
If you've never heard of "QaaS" technology you need to click here now.
Sell
34
JANX
Janux Therapeutics
Last Price:
41.31
Seasonality Move:
-14.57%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer2.jpg)
Fed rate cuts could send the stock market down
Here's my #1 free indicator to use now.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.
Janux Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.45 | Sell |
20-day SMA: | 42.94 | Sell |
50-day SMA: | 42.12 | Sell |
200-day SMA: | 32.92 | Buy |
8-day EMA: | 43.87 | Sell |
20-day EMA: | 43.35 | Sell |
50-day EMA: | 42.82 | Sell |
200-day EMA: | 35.2 | Buy |
Janux Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.71 | Buy |
Relative Strength Index (14 RSI): | 44.58 | Sell |
Chaikin Money Flow: | -858721 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.03 - 45.45) | Sell |
Bollinger Bands (100): | (39.45 - 51.03) | Sell |
Janux Therapeutics Technical Analysis
Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Janux Therapeutics Stock
Is Janux Therapeutics Stock a Buy?
- Janux Therapeutics share price is 41.26 while JANX 8-day simple moving average is 44.45, which is a Sell signal.
- The stock price of JANX is 41.26 while Janux Therapeutics 20-day SMA is 42.94, which makes it a Sell.
- Janux Therapeutics 50-day simple moving average is 42.12 while JANX share price is 41.26, making it a Sell technically.
- JANX stock price is 41.26 and Janux Therapeutics 200-day simple moving average is 32.92, creating a Buy signal.
JANX Technical Analysis vs Fundamental Analysis
Sell
34
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy or a Sell?
-
Janux Therapeutics stock is rated a Sell
The current Janux Therapeutics [JANX] share price is $41.26. The Score for JANX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Janux Therapeutics Stock Info
Market Cap:
2.15B
Price in USD:
41.26
Share Volume:
872.61K
Janux Therapeutics 52-Week Range
52-Week High:
65.60
52-Week Low:
5.65
Sell
34
Janux Therapeutics (JANX)
is a Sell
Janux Therapeutics Share Price Forecast
-
What is the Janux Therapeutics stock price today?
The Janux Therapeutics stock price is 41.26 USD today. -
Will JANX stock go up or go down?
Janux Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Janux Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Janux Therapeutics is overvalued.
Is Janux Therapeutics Stock a Buy?
- Janux Therapeutics share price is 41.26 while JANX 8-day exponential moving average is 43.87, which is a Sell signal.
- The stock price of JANX is 41.26 while Janux Therapeutics 20-day EMA is 43.35, which makes it a Sell.
- Janux Therapeutics 50-day exponential moving average is 42.82 while JANX share price is 41.26, making it a Sell technically.
- JANX stock price is 41.26 and Janux Therapeutics 200-day simple moving average is 35.20, creating a Buy signal.
Fundamental Analysis of Janux Therapeutics
Is Janux Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.07 per share, an increase this year of $0.19 per share, and a decrease next year of $0.46 per share.
Technical Analysis of Janux Therapeutics
Should I short Janux Therapeutics stock?
- JANX Moving Average Covergence Divergence (MACD) indicator is 0.71, suggesting Janux Therapeutics is a Buy
- Janux Therapeutics Relative Strength Index (RSI) is 44.58, which suggest Janux Therapeutics is oversold
- The Bollinger Bands (25) for Janux Therapeutics is (38.03 - 45.45), which suggest Janux Therapeutics is a Sell
- The Bollinger Bands (100) for Janux Therapeutics is (39.45 - 51.03), which suggest Janux Therapeutics is a Sell
* Janux Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.